Last Close
Mar 30  •  04:00PM ET
32.96
Dollar change
-0.15
Percentage change
-0.45
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y44.24% Total Holdings41 Perf Week-2.28%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM88.26M Perf Month-9.41%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter-15.23%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High40.10 -17.82% Perf Half Y12.52%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 75.48% Perf YTD-9.99%
Active/Passive Quant Type Tagsmedical Flows% 1M2.17% Volatility0.99% 1.22% Perf Year43.16%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M5.81% ATR (14)0.74 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD5.81% RSI (14)38.21 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.35 Perf 10Y-
Expense0.54% Growth/Value SMA20-3.65% Flows% 3Y Rel Volume0.63 Prev Close33.10
Inverse/Leveraged Market Cap SMA50-6.73% Flows% 5Y Avg Volume6.16K Price32.96
IPOOct 31, 2024 Option/ShortNo / Yes SMA2004.45% Trades Volume3,923 Change-0.45%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.